Clinical trialNCT05999084Enrolling, by, invitationObservational

Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry

SponsorEmory UniversityEnrollment735Alzheimer Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this registry is to compile information on patients who are receiving FDA-approved anti-amyloid mAbs in the course of their clinic visits in the Emory Cognitive Neurology Clinic and in Georgia Memory Net Memory Assessment Clinics.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

James J Lah, MD, PhD
Emory University
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Georgia Memory Net Memory Assessment Clinic - Albany
Albany, Georgia, United States
Emory Cognitive Neurology Clinic at the Emory Brain Health Center
Atlanta, Georgia, United States
Georgia Memory Net Memory Assessment Clinic - Atlanta
Atlanta, Georgia, United States
Georgia Memory Net Memory Assessment Clinic - Augusta
Augusta, Georgia, United States
Georgia Memory Net Memory Assessment Clinic - Gainesville
Gainesville, Georgia, United States
Georgia Memory Net Memory Assessment Clinic - Macon
Macon, Georgia, United States
Georgia Memory Net Memory Assessment Clinic - Savannah
Savannah, Georgia, United States
Georgia Memory Net Memory Assessment Clinic - Vidalia
Vidalia, Georgia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Anti-amyloid Monoclonal Antibodies

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 Mar 2025
Primary completion: 31 Jul 2028
Completion: 31 Jul 2028
Last update posted: 10 Jul 2026
Registered enrollment: 735
Registry id: NCT05999084

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.